Founded in 2020, Novocardia is the value-based care division of Cardiovascular Associates of America (CVAUSA), a comprehensive cardiology practice management services organization working with more than 450 cardiovascular clinicians across sixteen practices in eight states.  These clinicians collectively care for more than 750,000 patients. Novocardia is dedicated to developing and testing value-based care and contracting models and scaling them across the CVAUSA network--accelerating its clinicians’ ability to deliver the right care, in the right place, at the right time, for all Americans with cardiovascular disease.

At the recent DHNY Summit, our CEO, Frank Cheung, FSA, MAAA, moderated a panel that highlighted key considerations for providers when navigating from fee-for-service to value-based care models.